Biotech Startups

Polopo develops potatoes engineered to naturally produce more protein, using a patented method applicable to any potato variety. The high-protein potatoes are grown conventionally and processed into potato chips with three times more protein, aimed at brands making better-for-you snacks.

1 investor

Polymathic AI develops foundation models and machine learning for scientific data, aiming to build models that reuse shared concepts across disciplines for researchers. Its work includes an AI agent that determines organic molecular structure from raw experimental NMR data by treating the task as a constrained search over chemical space.

1 investor

Polymera develops biodegradable superabsorbent materials made from biopolymers produced by Antarctic bacteria, intended as a sustainable alternative to petroleum-based sodium polyacrylate used in the absorbent cores of disposable hygiene products such as diapers.

1 investor

PolyModels Hub develops ModelFlow, a platform for pharma process development that connects data, models, and teams to support biopharma workflows across therapeutic modalities including small molecules, oligonucleotides, biopharmaceuticals, and vaccines. It provides workflow libraries and model recommendations for process and product development across the drug development lifecycle.

1 investor

A company that has completed first-in-human clinical trials for its products and is pursuing regulatory approvals for worldwide commercialization.

1 investor

PolyPid is a biopharmaceutical company developing long-acting, controlled-release medicines delivered at the site of care, with a lead product D-PLEX100 using its proprietary Kynatrix technology for preventing surgical site infections. Its pipeline targets surgical care, metabolic diseases, and other therapeutic areas.

1 investor

Polyplus (a Sartorius company) develops FectoVIR-LV, an animal-component-free transfection reagent for producing lentiviral vectors in suspension HEK-293 cells at large manufacturing scale. It targets cell therapy producers, including those making CAR-T and other allogenic or autologous therapies, in the biomanufacturing sector.

1 investor

PolyXLabs is a biotechnology company that develops biodegradable, naturally derived polymers made from spent coffee grounds as a replacement for toxic, non-recyclable plastics for consumer goods companies. It offers customized chemical formulations for sustainable packaging and operates in the United States and Europe.

1 investor

PolyXLabs produces biodegradable plastic replacements made from spent coffee grounds and other lignocellulose-based biomass for consumer goods companies. The polymers are non-toxic, durable, and safely biodegrade without releasing microplastics.

1 investor

Ponce Aurora develops mitochondrial-targeting longevity products including a full-body treatment and energy beverages powered by MitoXcel™ technology, which addresses age-related decline in mitochondrial function. The company serves the consumer longevity and wellness market with information-based gerotherapeutics.

1 investor

Pono Tech offers Covalt, a collaborative platform for tracking loan covenants and collateral/securities with centralized data and automated reminders. It serves lenders and financing teams looking to manage credit risk and monitor their financing obligations.

1 investor

Pontifax is an investment firm that establishes and partners with biotech and healthcare companies across multiple therapeutic areas and development stages, providing hands-on portfolio management and strategic guidance.

1 investor

Poplar Therapeutics is a company whose website provides informational content; based on its name it operates in therapeutics/biotech, though the available page (a privacy policy) does not describe its specific products or focus.

1 investor

POROUS develops a non-invasive ultrasound-based medical device for quantitative bone quality assessment and osteoporosis detection. The company, spun off from Charité Universitätsmedizin Berlin, serves clinical and veterinary markets to improve bone health diagnostics and patient outcomes.

1 investor

Port Therapeutics is a company focused on cancer immunotherapy development.

1 investor

Portage is a clinical-stage immuno-oncology company developing novel cancer therapies with a portfolio in drug development. The company specializes in advancing cancer treatments through clinical development and regulatory pathways.

1 investor

Portal Biotech develops bench-top instruments that use nanopore biosensors coupled with machine learning to detect, sequence, and characterise single protein and metabolite molecules, revealing modifications, mutations, and isoforms. The technology, spun out of the Maglia Lab at the University of Groningen, serves academic research, biopharmaceutical, biotechnology, and industrial labs for proteomic and metabolomic analysis.

1 investor

Portal Innovations provides early-stage capital, laboratory space, and operational support to scientists and entrepreneurs building companies in emerging innovation ecosystems. The company connects breakthrough researchers with investors and corporate partners through deep university relationships and in-house scientific expertise.

1 investor

Portola develops research and investigates new targets, modalities, and technologies to address rare disease challenges for patients and their families.

1 investor

Potato builds software that connects scientific research intent to laboratory execution, enabling research teams to accelerate the translation from experimental design to hands-on lab work. The platform is designed for biotech and pharmaceutical research organizations seeking to reduce manual coordination and constraints in the experimental workflow.

1 investor

1 investor

Potsdam Science Park is a science and business park in the Golm district of Potsdam, Germany, hosting Max Planck and Fraunhofer institutes, University of Potsdam faculties, and research-focused companies in biotechnology, pharma, diagnostics, health, and new materials. Its site management provides services and support for scientists, students, startups, investors, and companies in the Berlin-Brandenburg region.

1 investor

Poxel is a clinical-stage biopharmaceutical company developing treatments for chronic metabolic diseases, including metabolic dysfunction-associated steatohepatitis and rare genetic disorders. The company is advancing drug candidates targeting metabolic pathways and has one approved product marketed in Japan.

1 investor

GMP Publications, Inc. provides training, auditing services, and compliance boot camps for companies and consumers in regulated industries including pharmaceuticals, medical devices, biologics, cosmetics, and dietary supplements.

1 investor